HealthCor Management as of March 31, 2020
Portfolio Holdings for HealthCor Management
HealthCor Management holds 45 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nevro (NVRO) | 7.5 | $175M | 1.8M | 99.98 | |
| Haemonetics Corporation (HAE) | 6.1 | $143M | 1.4M | 99.66 | |
| Aurinia Pharmaceuticals (AUPH) | 6.1 | $142M | 9.8M | 14.51 | |
| Laboratory Corp. of America Holdings (LH) | 5.8 | $137M | 1.1M | 126.39 | |
| Neurocrine Biosciences (NBIX) | 5.7 | $134M | 1.5M | 86.55 | |
| Teleflex Incorporated (TFX) | 5.1 | $119M | 407k | 292.86 | |
| Encompass Health Corp (EHC) | 4.2 | $98M | 1.5M | 64.03 | |
| ACADIA Pharmaceuticals (ACAD) | 4.0 | $94M | 2.2M | 42.25 | |
| Madrigal Pharmaceuticals (MDGL) | 4.0 | $94M | 1.4M | 66.76 | |
| Zimmer Holdings (ZBH) | 3.6 | $83M | 824k | 101.08 | |
| Blueprint Medicines (BPMC) | 3.2 | $75M | 1.3M | 58.48 | |
| Charles River Laboratories (CRL) | 3.2 | $74M | 585k | 126.21 | |
| CVS Caremark Corporation (CVS) | 3.1 | $73M | 1.2M | 59.33 | |
| Welltower Inc Com reit (WELL) | 3.1 | $72M | 1.6M | 45.78 | |
| Humana (HUM) | 2.7 | $64M | 204k | 314.02 | |
| Bausch Health Companies (BHC) | 2.5 | $59M | 3.8M | 15.50 | |
| Livanova Plc Ord (LIVN) | 2.4 | $56M | 1.2M | 45.25 | |
| Omega Healthcare Investors (OHI) | 2.3 | $54M | 2.0M | 26.54 | |
| Iqvia Holdings (IQV) | 2.2 | $52M | 479k | 107.86 | |
| UnitedHealth (UNH) | 1.8 | $43M | 171k | 249.38 | |
| CONMED Corporation (CNMD) | 1.7 | $39M | 688k | 57.27 | |
| Abbvie (ABBV) | 1.5 | $35M | 464k | 76.19 | |
| Mednax (MD) | 1.3 | $31M | 2.6M | 11.64 | |
| Amarin Corporation (AMRN) | 1.3 | $31M | 7.6M | 4.00 | |
| Medtronic (MDT) | 1.3 | $30M | 333k | 90.18 | |
| Pacira Pharmaceuticals (PCRX) | 1.3 | $30M | 887k | 33.53 | |
| Bluebird Bio (BLUE) | 1.2 | $29M | 622k | 45.96 | |
| Alexion Pharmaceuticals | 1.1 | $27M | 298k | 89.79 | |
| Horizon Therapeutics | 1.0 | $24M | 795k | 29.62 | |
| Becton, Dickinson and (BDX) | 1.0 | $23M | 100k | 229.77 | |
| Hologic (HOLX) | 0.9 | $22M | 625k | 35.10 | |
| Hca Holdings (HCA) | 0.9 | $21M | 230k | 89.85 | |
| Rts/bristol-myers Squibb Compa | 0.8 | $18M | 4.8M | 3.80 | |
| Arena Pharmaceuticals | 0.8 | $18M | 436k | 42.00 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $17M | 60k | 283.60 | |
| SPDR S&P Biotech (XBI) | 0.7 | $15M | 197k | 77.44 | |
| Biogen Idec (BIIB) | 0.6 | $15M | 48k | 316.38 | |
| Zymeworks | 0.6 | $15M | 417k | 35.47 | |
| Agios Pharmaceuticals (AGIO) | 0.6 | $15M | 409k | 35.48 | |
| Teva Pharmaceutical Industries (TEVA) | 0.6 | $13M | 1.5M | 8.98 | |
| Envista Hldgs Corp (NVST) | 0.6 | $13M | 888k | 14.94 | |
| Bristol Myers Squibb (BMY) | 0.4 | $9.7M | 174k | 55.74 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $5.2M | 370k | 13.95 | |
| RTI Biologics | 0.2 | $3.7M | 2.2M | 1.71 | |
| Polarityte | 0.0 | $687k | 636k | 1.08 |
